Designing Interactions with Multilevel Auditory Displays in Mobile Audio-Augmented Reality

Auditory interfaces offer a solution to the problem of effective eyes-free mobile interactions. In this article, we investigate the use of multilevel auditory displays to enable eyes-free mobile interaction with indoor location-based information in non-guided audio-augmented environments. A top-level exocentric sonification layer advertises information in a gallery-like space. A secondary interactive layer is used to evaluate three different conditions that varied in the presentation (sequential versus simultaneous) and spatialisation (non-spatialised versus egocentric/exocentric spatialisation) of multiple auditory sources. Our findings show that (1) participants spent significantly more time interacting with spatialised displays; (2) using the same design for primary and interactive secondary display (simultaneous exocentric) showed a negative impact on the user experience, an increase in workload and substantially increased participant movement; and (3) the other spatial interactive secondary display designs (simultaneous egocentric, sequential egocentric, and sequential exocentric) showed an increase in time spent stationary but no negative impact on the user experience, suggesting a more exploratory experience. A follow-up qualitative and quantitative analysis of user behaviour support these conclusions. These results provide practical guidelines for designing effective eyes-free interactions for far richer auditory soundscapes

Case study of ozone anomalies over northern Russia in the 2015/2016 winter: measurements and numerical modelling

Episodes of extremely low ozone columns were observed over the territory of Russia in the Arctic winter of 2015/2016 and the beginning of spring 2016. We compare total ozone columns (TOCs) from different remote sensing techniques (satellite and ground-based observations) with results of numerical modelling over the territory of the Urals and Siberia for this period. We demonstrate that the provided monitoring systems (including the new Russian Infrared Fourier Spectrometer IKFS-2) and modern three-dimensional atmospheric models can capture the observed TOC anomalies. However, the results of observations and modelling show differences of up to 20&thinsp;%–30&thinsp;% in TOC measurements. Analysis of the role of chemical and dynamical processes demonstrates that the observed short-term TOC variability is not a result of local photochemical loss initiated by heterogeneous halogen activation on particles of polar stratospheric clouds that formed under low temperatures in the mid-winter.</p

The CO2_{2} integral emission by the megacity of St Petersburg as quantified from ground-based FTIR measurements combined with dispersion modelling

The anthropogenic impact is a major factor of climate change, which is highest in industrial regions and modern megacities. Megacities are a significant source of emissions of various substances into the atmosphere, including CO$_{2}$ which is the most important anthropogenic greenhouse gas. In 2019 and 2020, the mobile experiment EMME (Emission Monitoring Mobile Experiment) was carried out on the territory of St Petersburg which is the second-largest industrial city in Russia with a population of more than 5 million people. In 2020, several measurement data sets were obtained during the lockdown period caused by the COVID-19 (COronaVIrus Disease of 2019) pandemic. One of the goals of EMME was to evaluate the CO$_{2}$ emission from the St Petersburg agglomeration. Previously, the CO$_{2}$ area flux has been obtained from the data of the EMME-2019 experiment using the mass balance approach. The value of the CO$_{2}$ area flux for St Petersburg has been estimated as being 89±28 kt km$^{-2}$ yr$^{-1}$, which is 3 times higher than the corresponding value reported in the official municipal inventory. The present study is focused on the derivation of the integral CO$_{2}$ emission from St Petersburg by coupling the results of the EMME observational campaigns of 2019 and 2020 and the HYSPLIT (HYbrid Single-Particle Lagrangian Integrated Trajectories) model. The ODIAC (Open-Data Inventory for Anthropogenic CO$_{2}$) database is used as the source of the a priori information on the CO$_{2}$ emissions for the territory of St Petersburg. The most important finding of the present study, based on the analysis of two observational campaigns, is a significantly higher CO$_{2}$ emission from the megacity of St Petersburg compared to the data of municipal inventory, i.e. ∼75800±5400 kt yr$^{-1}$ for 2019 and ∼68400±7100 kt yr$^{-1}$ for 2020 versus ∼30 000 kt yr$^{-1}$ reported by official inventory. The comparison of the CO$_{2}$ emissions obtained during the COVID-19 lockdown period in 2020 to the results obtained during the same period of 2019 demonstrated the decrease in emissions of 10 % or 7400 kt yr$^{-1}$

Perioperative Myocardial Infarction in Non-Cardiac Surgery Patients : A Prospective Observational Study

Background and Aims: Perioperative myocardial infarction is an underdiagnosed complication causing morbidity, mortality, and considerable costs. However, evidence of preventive and therapeutic options is scarce. We investigated the incidence and outcome of perioperative myocardial infarction in non-cardiac surgery patients in order to define a target population for future interventional trials. Material and Methods: We conducted a prospective single-center study on non-cardiac surgery patients aged 50years or older. High-sensitivity troponin T and electrocardiograph were obtained five times perioperatively. Perioperative myocardial infarction diagnosis required a significant troponin T release and an ischemic sign or symptom. Perioperative risk calculator was used for risk assessment. Results: Of 385 patients with systematic ischemia screening, 27 patients (7.0%) had perioperative myocardial infarction. The incidence was highest in vascular surgery19 of 172 patients (11.0%). The 90-day mortality was 29.6% in patients with perioperative myocardial infarction and 5.6% in non-perioperative myocardial infarction patients (p Conclusion: Perioperative myocardial infarction is a common complication associated with a 90-day mortality of 30%. The ability of the perioperative risk calculator to predict perioperative myocardial infarction was fair supporting its routine use.Peer reviewe

Poor 10-year survivorship of hip resurfacing arthroplasty: 5,098 replacements from the Finnish Arthroplasty Register

Background and purpose In a previous registry report, short-term implant survival of hip resurfacing arthroplasty (HRA) in Finland was found to be comparable to that of total hip arthroplasty (THA). Since then, it has become evident that adverse reactions to metal debris (ARMDs) may also be associated with HRA, not only with large-diameter head metal-on-metal THA. The aim of the study was to assess medium- to long-term survivorship of HRA based on the Finnish Arthroplasty Register (FAR).Patients and methods 5,068 HRAs performed during the period 2001-2013 in Finland were included. Kaplan-Meier survival analysis was used to calculate survival probabilities and their 95% confidence intervals (CIs). Cox multiple regression, with adjustment for age, sex, diagnosis, femoral head size, and hospital volume was used to analyze implant survival of HRA devices with revision for any reason as endpoint. The reference group consisted of 6,485 uncemented Vision/Bimetric and ABG II THAs performed in Finland over the same time period.Results The 8-year survival, with any revision as an endpoint, was 93% (CI: 92-94) for Birmingham Hip Resurfacing (BHR), 86% (CI: 78-94) for Corin, 91% (CI: 89-94) for ReCap, 92% (CI: 89-96) for Durom, and was 72% (CI: 69-76) for the Articular Surface Replacement (ASR). The 10-year survival, with any revision as an endpoint, for reference THAs was 92% (CI: 91-92) and for all HRAs it was 86% (CI: 84-87%). Female HRA patients had about twice the revision risk of male patients. ASR had an inferior outcome: the revision risk was 4-fold higher than for BHR, the reference implant.Interpretation The 10-year implant survival of HRAs is 86% in Finland. According to new recommendations from NICE (The National Institute for Health and Care Excellence), an HRA/THA should have a revision rate of 5% or less at 10 years. None of the HRAs studied achieved this goal

Effectiveness of conservative treatment for patellofemoral pain syndrome: A systematic review and meta-analysis

Objective: To evaluate the evidence regarding the effectiveness of conservative treatment in reducing patellofemoral pain.Data sources: CENTRAL, MEDLINE, CINAHL, and PE-Dro databases.Study selection: Adults with patellofemoral pain, randomized controlled trials only, any conservative treatment compared with placebo, sham, other conservative treatment, or no treatment. Two independent reviewers.Data extraction: Data were extracted from the full-text of the articles, based on Cochrane Collaboration recommendations. The outcome of interest was the difference between groups regarding change in pain severity.Data synthesis: The majority of studies were underpowered. More than 80% of the 37 trials did not show a clinically significant benefit. Clinically significant effects of different sizes were found for 7 trials (6 studies out of 7 had short follow-ups). These effects were found for: (i) pulsed electromagnetic fields combined with home exercise -33.0 (95% CI -45.2 to -20.8); (ii) hip muscle strengthening -65.0 (95% CI -87.7 to -48.3) and -32.0 (-37.0 to -27.0); (iii) weight-bearing exercise -40.0 (95% CI -49.4 to -30.6); (iv) neuromuscular facilitation combined with aerobic exercise and stretching -60.1 (95% CI -66.9 to -54.5); (v) postural stabilization -24.4 (95% CI -33.5 to -15.3); and (vi) patellar bracing -31.6 (95% CI -35.2 to -28.0).Conclusion: There is no evidence that a single treatment modality works for all patients with patellofemoral pain. There is limited evidence that some treatment modalities may be beneficial for some subgroups of patients with patellofemoral pain

Determination of HIV Tropism in Patients with Antiretroviral Therapy Failure in Arkhangelsk Region

The aim of the study was to determine the tropism of the human immunodeficiency virus in patients with virological failure of antiretroviral therapy (ART) from the Arkhangelsk Region based on the analysis of the env gene V3 loop nucleotide sequence.Materials and methods. We used blood plasma samples obtained from 76 HIV-infected persons from the Arkhangelsk Region with virological failure of antiretroviral therapy. The nucleotide sequences of the HIV env gene C2-V3-C3 region were studied by PCR followed by sequencing. The genotype of the studied strains was determined based on the analysis of their phylogenetic relations with reference sequences from the international GenBank database, as well as using specialized programs. To predict viral tropism, the Garrido rule and the online bioinformatic tool Geno2Pheno[coreceptor] were used. The Geno2Pheno[coreceptor] algorithm, determines the false positive rate (FPR) based on the analysis of the env gene V3 loop nucleotide sequence. Results and discussion. Significantly lower representation of R5X4/X4-tropic HIV variants in long-term infected persons with subsubtype A6 virus compared to subtype B virus has been shown. For all FPR cut-off algorithms, a significant correlation between subtype and HIV tropism was observed (p=0.0014 and p=0.013 for FPR 10 % and FPR 20 %, respectively). While among subtype B strains, at least 57 % were identified as R5X4/X4-tropic variants (for an FPR of 10 %), including two strains classified as X4-tropic; among HIV subsubtype A6 even at an FPR of 20 %, the frequency of R5X4/X4-tropic samples only slightly exceeded 22 %. It can be assumed that the dynamics of changes in HIV tropism depends on the virus subtype. Significant differences in the distribution of amino acid residues of the V3 region sequences in the examined group between R5-tropic and R5X4/X4-tropic strains of subsubtype A6 for positions 18 (χ2=7.616, p=0.0058), 21 (χ2=7.281, p=0.007), 24 (χ2=5.587, p=0.0181), and 34 (χ2=5.144, p=0.0233) have been demonstrated. Among the R5X4/X4-tropic strains of the A6 subsubtype, amino acid substitutions were registered at positions 6, 19, 21, 26, 29, 30, which were not found in the R5-tropic A6 strains. The high occurrence frequency of a number of mutations previously described as presumably associated with resistance to maraviroc and similar drugs may indicate a natural polymorphism characteristic of the A6 subsubtype, which does not correlate with resistance to CCR5 co-receptor antagonists

A report of Streptococcus pneumoniae serotype 6D in Europe

Serotype 6D of Streptococcus pneumoniae has been reported in Asia and the Fijian islands among nasopharyngeal carriage isolates. We now report a 6D isolate from a Finnish adult with invasive pneumococcal disease. Interestingly, the Finnish isolate and Asian isolate capsule gene loci are almost identical